Physician profile
Vikas Gupta
NPI 1770526964
$7,109.32
in general payments reported to CMS, 2019-2025
53 companies · $1,952 in 2025
The $1,952 reported for 2025 was more than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.00 · 2021: $61.92 · 2022: $261 · 2023: $1,878 · 2024: $2,870 · 2025: $1,952.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,525 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,524.95 |
| Education | $174.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $760.59 | 2022-2025 | |
| Exelixis INC. | $529.00 | 2021-2025 | Cabometyx |
| Daiichi Sankyo INC. | $511.53 | 2023-2025 | Enhertu, Injectafer |
| Astrazeneca Pharmaceuticals Lp | $442.26 | 2023-2025 | Imfinzi, Tagrisso, Enhertu |
| Merck Sharp & Dohme LLC | $350.29 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $341.82 | 2023-2025 | |
| Amgen INC. | $286.54 | 2019-2023 | Lumakras, Xgeva, Nplate |
| Gilead Sciences, INC. | $238.15 | 2021-2025 | Trodelvy |
| Janssen Biotech, INC. | $230.65 | 2023-2025 | Darzalex, Tecvayli, Talvey |
| Lilly USA, LLC | $206.75 | 2024-2025 | Verzenio, Jaypirca |
| Sobi, INC | $191.81 | 2024-2025 | |
| Glaxosmithkline, LLC. | $180.42 | 2023-2025 | Ojjaara, Zejula, Jemperli |
| Genentech USA, INC. | $165.98 | 2023-2025 | Tecentriq, Polivy, Lunsumio |
| Celgene Corporation | $152.50 | 2022-2025 | Reblozyl, Opdualag, Pomalyst |
| Beigene USA, INC. | $146.13 | 2023-2025 | Brukinsa |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kite Pharma, INC. | $133.05 | 2022-2023 | |
| Tempus Ai, INC | $128.59 | 2024-2025 | Xt Cdx |
| Servier Pharmaceuticals LLC | $110.48 | 2023-2025 | |
| Ipsen Biopharmaceuticals, INC | $109.78 | 2023-2025 | Onivyde, Somatuline Depot |
| E.R. Squibb & Sons, L.L.C. | $105.71 | 2023-2025 | Opdivo |
| Abbvie INC. | $100.01 | 2023-2025 | |
| Incyte Corporation | $94.79 | 2023-2025 | Monjuvi, Jakafi, Zynyz |
| Dendreon Pharmaceuticals LLC | $94.34 | 2024 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $91.88 | 2023-2025 | |
| Karyopharm Therapeutics INC. | $91.65 | 2024-2025 | Xpovio |
| Regeneron Healthcare Solutions, INC. | $90.32 | 2023-2025 | Libtayo, Lynozyfic |
| Alexion Pharmaceuticals, INC. | $88.24 | 2023-2024 | Ultomiris |
| Seagen INC. | $87.60 | 2023 | Padcev, Tukysa, Adcetris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $87.43 | 2023-2024 | Gilotrif |
| Astellas Pharma US INC | $74.29 | 2024-2025 | Xospata, Vyloy, Padcev |
| Emd Serono, INC. | $73.43 | 2023-2024 | Bavencio |
| Takeda Pharmaceuticals U.S.A., INC. | $70.63 | 2023-2025 | Fruzaqla, Alunbrig |
| Stemline Therapeutics INC. | $68.29 | 2023-2024 | Orserdu |
| Mirati Therapeutics, INC. | $55.74 | 2023-2024 | Krazati |
| Array Biopharma INC | $55.24 | 2024-2025 | Braftovi, Mektovi, Xalkori |
| Springworks Therapeutics, INC. | $51.27 | 2024 | Ogsiveo |
| Puma Biotechnology, INC. | $50.12 | 2023-2025 | |
| Beone Medicines USA, INC. | $48.09 | 2025 | Brukinsa |
| Kyowa Kirin, INC. | $47.04 | 2023-2024 | Poteligeo |
| Pharmacyclics LLC, An Abbvie Company | $44.66 | 2023 | Imbruvica |
| Eisai INC. | $44.27 | 2023-2024 | |
| Agios Pharmaceuticals, INC. | $41.20 | 2023-2024 | Pyrukynd |
| Sun Pharmaceutical Industries INC. | $36.85 | 2022 | |
| Genmab U.S., INC. | $24.98 | 2024 | Epkinly |
| Adaptive Biotechnologies Corporation | $24.95 | 2024 | Clonoseq |
| Cti Biopharma Corp. | $24.56 | 2023 | Vonjo |
| Taiho Oncology, INC. | $24.42 | 2024 | |
| Genzyme Corporation | $19.04 | 2024 | |
| Harmony Biosciences LLC | $17.96 | 2024 | |
| Sumitomo Pharma America, INC. | $17.70 | 2025 | Orgovyx |
| Jazz Pharmaceuticals INC. | $16.09 | 2024 | |
| Octapharma USA, INC. | $15.12 | 2023 | Octagam Immune Globulin (Human) |
| Accord Healthcare, INC. | $15.09 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.